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Background: Postoperative complications after major surgery are thought to be associated
with reduced fitness. Surgical cancer patients are often malnourished, cachexic and subject
to neoadjuvant chemotherapy resulting in low preoperative fitness levels. This review ex-
amined the associations between aerobic fitness, as determined objectively by preoperative
cardiopulmonary exercise testing (CPEX), and short-term morbidity after cancer surgery.
Methods: A literature search using databases of PubMed, Medline, Embase, Cumulative
Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Library for
studies that examined associations between preoperative CPEX variables and postopera-
tive complications following surgery for the ten commonest cancers.
Results: A total of 21 observational studies were identified with 4957 patients that under-
went CPEX testing prior to lung, colorectal, liver, oesophagogastric, bladder and pancreas
resections. The median sample size was 105 patients (range 64 - 1684). No studies were
found for breast or brain cancers or lymphoma. In lung cancer patients undergoing thoracot-
omy, a VO2peak ≤ 15ml/kg/min was associated with an increased risk of respiratory complica-
tions and death. None of the studies in other cancer types had adequate sample sizes to re-
port on mortality. CPEX testing had mostly poor to average discriminatory accuracy to pre-
dict postoperative morbidity in other cancer resection surgeries. Findings across studies
were inconsistent, and detection and selective reporting biases were likely to be significant.
Conclusion: The utility of CPEX testing prior to cancer surgery is questionable and cur-
rently should not be used as a discriminatory tool, except in patients undergoing lung can-
cer resection by thoracotomy. Larger studies with more robust methodologies are currently
required to determine the utility of CPEX.
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Surgical stress response following major sur-gery results in muscle wasting and systemic in-flammation,with a large increase in tissue oxy-
gen demand and consumption (1); increasing the
risk of ischaemic events (2). Furthermore, postop-
erative bed-rest and incisional pain inhibits normal
lung mechanics, promoting shallow breathing, at-
electasis and infective lung consolidation (3).
These physiological challenges are in part met by a
patient’ s cardiopulmonary reserves, or their abili-
ty to increase cardiac output and ventilation to
meet increased demand. Such reserves are greater
in physiologically ‘fitter’ patients. Cancer patients
represent a specific population, more likely to
have underlying malnutrition and cachexia than
non-cancer patients, with depleted fitness levels
(4, 5). Neoadjuvant chemotherapy has also been
shown to independently reduce aerobic fitness (5).
By measuring a patient’ s preoperative cardiopul-
monary reserve, or functional capacity, wemay hy-
pothetically be able to discriminate patients that
may ormay not tolerate the physiological insult as-
sociated with surgery. Therefore, measurement of
preoperative fitness may serve as a preoperative
risk prediction tool for the development of compli-
cationsprior tomajorcancer resection.
Cardiopulmonary exercise testing (CPEX) of-
fers a quantitative and composite measure of
functional reserve, where a low score indicates a
patient’ s inability to effectively transfer oxygen
to tissues on exertion. The test is carried out in
laboratory conditions usually on a static exercise
bike, where pedal resistance, or workload, is sys-
tematically increased until volitional termina-
tion. Two important CPEX variables are cap-
tured by analysis of gas exchange at the mouth,
VO2peak (the maximal oxygen consumed at the
peak of exercise) and VO2 at estimated anaerobic
threshold (AT), a measure of sustainable aerobic
activity. Both parameters have shown promise in
observational studies in predicting both morbidi-
ty and mortality after major elective surgery (6).
In a seminal study from 1993, of 187 elderly pa-
tients undergoing major abdominal surgery, a
preoperative AT cut-off of 11ml / kg /min had a
sensitivity of 91% and specificity of 74% for pre-
dicting postoperative mortality after major ab-
dominal surgery (7). Since then, multiple, often
small, observational studies have been published
in various cancer surgery specialties. However,
the results from these are inconsistent, possibly
explained by biases inherent in the methodology
such as performance and detection biases (due to
unblinded clinical teams and outcome assessors,
respectively) as well as selective reporting bias,
which is likely to be substantial (8). Although 3
reviews of CPEX testing and major surgeries
have been published (6, 9, 10), all included non-
cancer patients and excluded common cancers
such as lung and bladder. Furthermore, impor-
tant sources of bias do not appear to be have
been adequately addressed previously. The aim
of this article was to assess the association be-
tween CPEX testing and short-term postopera-
tive morbidity and mortality after common ma-
jor cancer resection surgery; with due consider-
ation of potential biases both in terms of their
magnitude and direction. If a convincing inverse
association exists, it may not only support the
preoperative use of CPEX to determine operabil-
ity and postoperative monitoring and manage-
ment, but also identify fitness as a modifiable
risk factor for investigation in randomized con-
trolled trials of surgical cancer patients.
METHODS
The preferred reporting items for systematic re-
views (PRISMA) guidelines were used to stan-
dardize the methods of conducting and report-
ing this review. The ten commonest causes of
cancer deaths in the UK in 2014 were identified
(lung, bowel, breast, prostate, pancreas, oesoph-
agus, bladder, brain, liver, lymphoma) (11), and
a literature search was conducted using
PubMed, Medline, Embase, CINAHL and the
Cochrane library (from commencement to 5th
July 2017) for studies that examined associa-
tions between preoperative CPEX and postoper-
ative complications following cancer resection
surgery. The search terms used were: CPEX,
CPET, exercise testing, anaerobic threshold,
VCO2, ventilatory inefficiency, oxygen consump-
tion, VO2, preoperative exercise, aerobic exer-
cise. For each cancer, additional specific search
terms were added (Supplementary Appendix 1).
We included analytical studies (cohort, case-con-
trol, randomized controlled trials) that investi-
gated the association between preoperative
CPEX variables and short-term (up to 90 days)
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morbidity and mortality. Studies were excluded
with sample sizes <100 patients, unless there
were <2 studies in that surgical population in
which case the total sample size needed to be at
least 60, which was considered the minimum
size to determine associations with a moderate
event rate. In order to select studies which exam-
ined only cancer populations, studies with a
large proportion (≥ 25%) of non-cancer patients
were also excluded (unless cancer patients were
analysed separately) as were investigations that
combined multiple surgical patient populations
(e.g. colorectal, urological and upper gastrointes-
tinal cancer patients), unless these groups were
sub-analysed.
RESULTS
A total of 21 hospital-based cohort studies (12
prospective, 9 retrospective) were included in
this review with a total of 4957 patients that un-
derwent CPEX testing prior to lung (12-17),
colorectal (18-20), liver (21-23), oesophagogas-
tric (24-26), bladder (27-29) and pancreas resec-
tion (30-32) (Figure 1). No studies were found in
breast, brain or lymphoma cancers. No random-
ized controlled trials of any cancer site were iden-
tified. Data were extracted from each study (in-
cluding study design, sample size, outcome mea-
surement and effect sizes) and tabulated (Table 1).
Lung Cancer
Four hundred and three studies were identified,
with 63 potentially relevant papers by title. A re-
view of these abstracts identified 23 potentially
relevant papers. Six studies met the inclusion cri-
teria and were included in this review (12-17).
All were observational cohort studies (2 prospec-
tive, 4 retrospective), with a total of 2814 pa-
tients from hospitals within Europe and the
USA. The largest study was a retrospective analy-
sis of 1684 patients who had lung cancer sur-
gery identified from the European Society of
Thoracic Surgeons (ESTS) database (12), which
is voluntarily contributed to by clinicians from
235 sites across Europe. The authors reported
no association between VO2peak and all-cause
morbidity (for either video-assisted thoracoscop-
ic surgery (VATS) or thoracotomy resections),
but a significant association with mortality in pa-
tients undergoing thoracotomy resection with a
VO2peak < 15ml/kg/min (P = 0.008). Whilst this
study had several strengths including, a large
sample size and use of propensity matching to
reduce selection bias, it had significant limita-
tions, which are acknowledged by the authors.
The largest of these was the potential for mea-
surement error (for complications) through the
use of a voluntary multi-institutional database,
where the accuracy of the data entry has not
been validated (12). Inaccurate recording of out-
come would lead to an attenuation of any associ-
ations between CPEX variables and outcome.
The second largest study was a multi-center (9
centers) prospective observational investigation
of 346 patients from the USA who underwent
thoracotomy and lung cancer resection surgery
(13). In contrast to the results of the previous
study, the authors reported that VO2peak was sig-
nificantly lower in the group with complications
(15.2 ml / kg / min) compared to those without
(16.7 ml /kg /min) although the mean difference
was small: -1.47 ml/kg/min (95% CI 0.55-2.4),
P = 0.002. The authors also undertook a further
sub-analysis in patients with the outcomes of re-
spiratory failure (n = 33) and death (n = 15).
Both events were associated with a lower mean
VO2peak (14.7 ml/kg/min), P = 0.041 compared to
those without complications (mean difference 2
ml/kg/min), although the small number of events
is noted. Whilst the large sample size, prospec-
tive design and multi-center participation in-
creases power, reduces bias and enables general-
isability, respectively, there were limitations. A
pre-defined criterion for what constituted each
complication was not established, nor were the
post-operative outcomes measured in a blinded
fashion, both of which could contribute to detec-
tion bias resulting in spurious over-estimation of
the associations found. Furthermore, the authors
defined postoperative morbidity as a composite
outcome, which included complications lacking
a clear plausible mechanistic relationship with
aerobic fitness; such as red blood cell transfu-
sions (n = 38). Such an event is more likely to be
associated with intra-operative blood loss (per-
haps due to longer operating times in patients
with underlying lung disease), suggesting that re-
sidual confounding may explain some of the as-
sociations found.
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Figure 1. The PRISMA Diagram.
The other 4 studies in lung cancer patients
were all hospital-based cohort studies, which re-
ported inconsistent findings (14-17). Two of the
investigations were by the same research group
(15, 17), which reported an inverse association
between VO2peak and respiratory complications
(P = 0.015) in one of their studies (15), but were
unable to subsequently replicate this finding
(P = 0.5) in the other despite similar methodolo-
gies and patient populations (17). Detection bias
due to non-blinded assessment may have contrib-
uted to the variability in findings. The two other
studies reported an inverse association between
VO2peak and cardiopulmonary complications, OR
0.05 (95% CI 0.01-0.58), P = 0.0216 and OR
0.79, 95% CI 0.71-0.88, P ≤ 0.0001 (14). How-
ever, the large variation in the effect size esti-
mates and large confidence intervals reflects the
imprecision of the findings. Again, outcome as-
sessment was not blinded, which may have spuri-
ously inflated the reported effect sizes.
Author’ s summary: Observational studies
have reported that VO2peak appears to be associat-
ed with complications after lung cancer resection
surgery. More specifically, the two largest studies
reported that a VO2peak <15 ml/kg/min was associ-
ated with an increased risk of respiratory failure
(13) and death following lung cancer resection
by thoracotomy (12, 13). However, only one
study in lung cancer surgery examined outcomes
after VATS and found no association between
VO2peak and morbidity or mortality (12). As VATS
is increasingly becoming used for lung cancer re-
section, the utility of CPEX testing needs to be
updated to determine if it is of value in less inva-
sive surgeries for lung cancer resection.
Colorectal Cancer
The literature search identified 431 studies, of
which 30 were considered relevant based on
their title. These were reduced to 13 after read-
ing the abstracts, of which 3 met the inclusion cri-
teria and were included in this review (18-20).
The main reason for excluding other investiga-
tions was their inclusion of > 25% of non-cancer
patients. All 3 were observational studies from
the same UK group. The largest was a retrospec-
tive multi-center (6 sites) UK investigation of 703
patients (20), most of which had a malignant dis-
ease (87%). In contrast to the studies in lung can-
cer surgery, all-cause morbidity was measured us-
ing a validated PostOperative Morbidity Survey
(POMS) at postoperative day 5 (33, 34). The se-
verity of complications was graded using the sys-
tem devised by Clavien and Dindo (34). This
grading system is based upon the level of inter-
vention required to treat a complication; from
normal postoperative adjuncts such as supple-
mentary oxygen, analgesia and anti-emetics
(grade 1), to additional medicines above usual
standard care, including antibiotics (grade 2).
Grade 3 is a complication requiring operative in-
tervention and grade 4 complications require or-
gan support in critical care. The authors reported
a significant difference in both median VO2peak
and AT in patients with and without all-cause
morbidity of any Clavien-Dindo grade (P =
0.031 and P = 0.002, respectively). Receiver Op-
erator Characteristic (ROC) Curve analyses were
also undertaken to shows how sensitivity and
specificity varied with changing thresholds,
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which was expressed as an area under the ROC
curve (AUC). The AUC takes into consideration
the accuracy of a diagnostic test (in terms of sen-
sitivity and specificity) across a range of thresh-
old values (35). In the context of CPEX testing,
where the association may be inverse, the AUC is
equal to the probability that if a pair of patients
(one with a complication and one without) are
selected at random, the patient with a complica-
tion will have a lower CPEX value than the com-
plication-free patient (35). An AUC of 1.0 indi-
cates a perfect test and 0.5 a completely uninfor-
mative test i. e. a result occurring by chance. An
AUC of <0.7 would be indicative of a poor pre-
dictive test, 0.7-0.8 average accuracy and > 0.8
good accuracy as a diagnostic test across a range
of thresholds (35). In this study, AT had average
discrimination (i. e. 0.70-0.80) with an AUC of
0.79, 95% CI 0.76-0.83 with an optimal cut-
point at 11.1 ml / kg / min (78% sensitivity and
71% specificity). The AUC for VO2peak was 0.77,
95% CI 0.71-0.82 with an optimal cut-point of
18.2ml/kg/min (70% sensitivity and 72% speci-
ficity). However, similar to the previous studies
in lung cancer, outcome assessors were not blind-
ed to CPEX data, so detection bias could explain
the associations found. Indeed, there were signif-
icant variations (P ≤ 0.001) in AUC values across
recruited hospital sites (supplementary material),
where the largest recruiting center (n = 239) had
more modest values for VO2peak (AUC 0.73) and
AT (AUC 0.68) compared to the above-pooled
values quoted in the study. Complications with-
out a clear plausible relationship with aerobic fit-
ness were associated with CPEX values includ-
ing; postoperative pain and gastrointestinal
symptoms (such as ileus). Therefore, residual
confounding may explain some inverse associa-
tions found. The same group previously pub-
lished a prospective blinded observational study
in 136 patients undergoing colonic surgery, most
of whom (89%) had a malignant disease (19).
With detection bias removed, the predictive per-
formance of CPEX for day 5 morbidity was poor
(i.e., AUC <70). For AT the AUC was 0.63, 95%
CI 0.54-0.73, with a lower optimal cut-point at
10.1 ml/kg/min (68% sensitivity and 58% speci-
ficity). The AUC for VO2peak was 0.63, 95% CI
0.53-0.73 with an optimal cut-point of 16.7 ml/
kg / min (55% sensitivity and 69% specificity).
Furthermore, 14% of their sample who under-
went CPEX testing and surgery were excluded as
they “lacked complete data”. It is unclear wheth-
er this data was missing at random, and may
therefore represent a source of selection bias.
The final study by the same group investigat-
ed 95 rectal cancer patients undergoing resec-
tion surgery, 68 of whom received neoadjuvant
treatment (18). Morbidity and mortality were
measured blinded, using the same methods re-
ported in their other work (19, 20). Both VO2peak
and AT were associated with total morbidity at
day postoperative day 5. For AT, the AUC
showed good accuracy at 0.87 (95% CI 0.79-
0.95) with an optimal cut-point of 10.6 ml /kg/
min (84% sensitivity and 92% specificity).
VO2peak had an AUC of 0.85 (95% CI 0.77-0.93)
and cut-point of 18.6 ml/kg/min (82% sensitivi-
ty and 80% specificity). However, the small sam-
ple size increases the risk of a chance finding.
Author’ s conclusion: Overall the association
between preoperative CPEX and postoperative
outcome following colorectal cancer surgery is
derived from observational studies by the same
research group. There does appear to be inverse
associations between VO2peak and AT and all-
cause morbidity at day 5 post surgery. However,
detection bias and residual confounding cannot
be excluded. Furthermore, 5-day POMS morbid-
ity measured complications of a low severity
(Clavien-Dindo ≤ 2) in the majority of patients,
which makes the clinical usefulness of these find-
ings questionable. POMS has also not been vali-
dated as an index of overall morbidity (33). The
decision of whether or not to undergo surgery is
unlikely to be meaningfully informed by this
work. Larger multicentre studies are required to
address whether improved fitness prior to
colorectal surgery reduces the risk of major post-
operative outcomes including death, with out-
come assessment blinded to CPEX data.
Liver Cancer
One hundred and eight studies were identified
using the search terms, of which 7 were consid-
ered relevant based on their title. These were re-
duced to 4 after reading the abstracts and 3 met
the inclusion criteria and were included in this
review (21-23). All 3 were UK hospital-based co-
hort investigations (2 prospective and 1 retro-
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spective) of patients that underwent both major
and minor hepatectomies (21-23). The largest, a
retrospective study of 197 patients, found no as-
sociation between in-hospital morbidity and
VO2peak or AT (22). The study did not measure
complications using a validated outcome mea-
sure or blind its assessors to CPEX values. How-
ever, the result of such bias may inflate, rather
than reduce, the effect size reported. The second
largest study, a UK prospective cohort of 104 pa-
tients, did report an association between both
VO2peak, AT and complications (23). This used a
validated outcome measure (POMS) with asses-
sors blinded to the CPEX scores. However, the
authors chose to report complications at postop-
erative day 3. This timeframe was not defended
in the study, and in the absence of a pre-defined
protocol, selective reporting bias cannot be
ruled out, which may have produced a false posi-
tive result. Furthermore, the high complication
rate (70%) likely reflects routine, less severe,
postoperative interventions (pain medication,
urinary catheter, oxygen supplementation),
which are likely to be clinically insignificant and
rare beyond day 3 (33). When the authors grad-
ed complication severity according to Clavien-
Dindo they found no associations between
CPEX variables and complications of grade 3
(needing surgical intervention) or above. The fi-
nal study was a UK prospective cohort investiga-
tion of 92 patients, which reported no associa-
tion between VO2peak or AT and 30-day morbidi-
ty (as measured by POMS) (21). The authors did
document that VE / VCO2 (a CPEX measure of
ventilatory efficiency) was associated with com-
plications, but its predictive value was poor;
where a value of 34.5 provided a sensitivity of
47% for complications.
Author’ s summary: The evidence base for
CPEX and liver cancer surgery is derived from
small observational studies with poor quality
outcome reporting. From the evidence to date,
there is insufficient data demonstrating an associ-
ation between CPEX and outcome following he-
patic resection. A large well designed multicen-
tre study is needed to assess the role of preopera-
tive CPEX in liver cancer surgery.
Oesophageal Cancer
Four hundred and seventy-eight studies were
identified of which 11 were considered relevant
based on their title, reduced to 5 after reading
the abstracts. Of these, 3 met the inclusion crite-
ria and were included in this review (24-26). All
3 were retrospective hospital-based cohort stud-
ies with small sample sizes from single institu-
tions. The largest was a Japanese analysis of 91
patients who underwent McKeown oesophagec-
tomy for squamous cell carcinoma (26). Only
cardiopulmonary complications were measured
and occurred in 19% of patients. The mean
VO2peak was found to be lower in those with, vs.
those without cardiopulmonary complications
(789 ml/min/m2 vs. 966 ml/min/m2, t-test, P ≤
0.001). These values approximate to 20.9 ml/kg/
min vs. 25.6 ml/kg/min [conversion using the av-
erage height and weight of a Japanese male]
(36). No association was found between AT and
complications (t-test, P = 0.12). The second
largest study was a UK investigation of 78 pa-
tients, predominantly with adenocarcinoma
(74%), undergoing oesophagectomy (64% with
neoadjuvant chemotherapy) (24). Cardiopulmo-
nary outcomes occurred in 42% of patients (n=
33) and non-cardiopulmonary in 24% (n=19).
Similar to the Japanese study, a low mean VO2peak
was associated with cardiopulmonary complica-
tions although the mean difference was small
(19.2 ml/kg/min in those with complications vs.
21.4 ml / kg / min in those without, t-test, P =
0.04). AT was also not associated with complica-
tions (13.2 ml / kg /min in those with complica-
tions vs. 14.4 ml/kg/min in those without, t-test,
P = 0.07). ROC curve analysis estimated the
predictive value of both VO2peak and AT to be
poor (i.e., < 70), AUC 0.63 (95% CI 0.50-0.76,
P = 0.02) and 0.62 (95% CI 0.49-0.75, P =
0.03), respectively. The same group subsequent-
ly published a further study of 103 patients with
both oesophageal and gastric cancers that under-
went CPEX testing prior to oesophagectomy
(62%) and gastrectomy (25). The findings were
the reverse of their previous work, in that, this
time; a lower AT was associated with cardiopul-
monary complications (9.9 ml / kg /min in those
with complications vs. 11.2 ml/kg/min in those
without, P = 0.05), while VO2peak was not (16.6
ml/kg/min in those with complications vs. 14.6
ml / kg /min in those without, P = 0.07). ROC
analysis again reported both AT and VO2peak to
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be poorly predictive of complications (AUC
0.62 (95% CI 0.50-0.74, P = 0.06) and 0.60
(95% CI 0.48-0.72, P = 0.08, respectively). The
most significant limitations of all three studies,
apart from their small sample sizes and single in-
stitution design are the potential for detection bi-
as for complications due to unblinded outcome
assessments, particularly for complications
which can be subjectively diagnosed (e.g. pneu-
monia). This could lead to an over-estimate of
the association between CPEX variables and out-
comes. Such methodological error may explain
why the same group were unable to replicate
their previous findings (24, 25).
Author’ s conclusion: Associations between
CPEX variables and outcome after oesophagec-
tomy are from small retrospective observational
studies that did not use a validated measure of
postoperative outcomes, or capture complica-
tions with blinding to CPEX values. The ab-
sence of blinding could result in an inflation of
the association between CPEX values and post-
operative outcomes. Further large studies where
complications are strictly defined and measured
by assessors blinded to CPEX values are needed.
Bladder Cancer
Thirty-five studies were identified, with 9 poten-
tially relevant papers identified by their title. A
review of these 9 abstracts identified 5 potential-
ly relevant papers, but only 3 met the inclusion
criteria. All were prospective hospital-based co-
hort studies, with a total of 256 patients from
hospitals in the UK (27-29). The largest was of
105 patients who underwent preoperative
CPEX testing prior to either robot-assisted (n=
38) or open (n=67) cystectomy (28). Complica-
tions were measured at day 90 by blinded asses-
sors and were associated with a significantly low-
er median AT (10.6 vs 11.8, U-test, P = 0.007)
and VO2peak (14.3 vs 15.4, U-test, P = 0.02) com-
pared to those without complications. Addition-
ally, VE/VECO2 was higher in the complication
group than in those without (33.3 vs 30.3, U-
test P=0.007). Whilst these findings are convinc-
ing in that there was consistency of associations
across 3 CPEX values, the small study sample
from a single institution presents a significant
limitation to a more generalized interpretation
of the results. The second largest study was of
82 patients who underwent CPEX prior to intra-
corporal robotic-assisted radical cystectomy
(29). There were no associations between any
CPEX variable and outcome. However, the
small sample size and small number of complica-
tions (n=14) likely result in a lack of statistical
power to detect a clinically meaningful associa-
tions with CPEX. The smallest prospective co-
hort study was of 69 patients undergoing radical
cystectomy. Again, no CPEX values were predic-
tive of complications when the patients were di-
vided into two groups, composed of those with
and without a complication. However, sub-anal-
ysis according to the presence of a Clavien-Din-
do grade ≥ 3 complication (n = 13 vs n = 56)
found an inverse association between AT and
major complication risk, OR 0.74 (95% CI 0.57-
0.97). Again, the results of this single institution
study with a small sample size are difficult to in-
terpret, particularly when post-hoc analyses ac-
cording to different complication severities were
undertaken, which increase the risk of a chance
finding in a small sub-group.
Author’s summary: The evidence of an associ-
ation between CPEX and post-cystectomy out-
come is from small single-institution studies,
which report conflicting findings. Therefore
larger studies which limit sources of bias are re-
quired to clarify whether an association exists.
Pancreatic Cancer
Thirty-one studies were identified, with 8 poten-
tially relevant papers by title. A review of these
8 abstracts identified 3 potentially relevant pa-
pers and all 3 met the inclusion criteria (30-32).
These were UK hospital based-cohort studies (2
retrospective, 1 prospective) with a total of 288
patients. None of the studies used blinded out-
come assessments. The largest was a retrospec-
tive study of 124 patients who had CPEX test-
ing prior to pancreaticoduodenectomy (30).
Complications occurred in 44% of patients and
were defined using POMS (33) and the Interna-
tional Study Group definition of Pancreatic Fis-
tula (ISGPF) (37). There were no associations
between VO2peak and complications, including
pancreatic leak. AT was dichotomised using a
cut-point of 10.1 ml / kg / min (a value derived
from their previous work) (38), and included in
a multivariable logistic regression model, which
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estimated that AT <10.1ml / kg /min greatly in-
creased the odds of a pancreatic leak, OR=5.79
(95% CI 1.62-20.63). The imprecision of this es-
timate likely reflects both the dichotomisation of
a continuous variable and the small pancreatic
leak events in the total sample (n=29). The sec-
ond largest study was a retrospective analysis of
100 patients that underwent preoperative CPEX
and major pancreatic surgery (98% pancreatico-
duodenectomy) (31). Again, AT was dichoto-
mized, rather than treated as a continuous vari-
able. The point of dichotomization (10 ml / kg /
min) was not justified in the report and unclear
if chosen a priori. The results showed a greater
incidence of pancreatic leak (occurring in 25 pa-
tients), when AT was < 10ml/kg/min (35.4% vs.
16%, P = 0.028). However, statistical signifi-
cance was lost when leaks were graded accord-
ing to the ISGPF classification (P = 0.091). Se-
lective reporting bias cannot be excluded, partic-
ularly when a seemingly arbitrary threshold was
used to dichotomize a continuous variable. Fur-
thermore, dichotomization during analysis re-
sults in a loss of statistical power and increases
the risk of a false positive result (39). The final
investigation was a prospective cohort study of
64 patients undergoing pancreaticoduodenecto-
my, which included a per-protocol statistical
analysis (32). The authors reported no associa-
tion between AT or VO2peak and all complica-
tions, OR 1.07 (95% CI 0.83-1.39) and OR
1.00 (95% CI 0.86-1.18), respectively.
Author’ s summary: The studies in pancreatic
cancer have small patient numbers and potential
sources of detection and selective reporting biases
which makes interpretation of their findings diffi-
cult. Similar to other cancer resection surgeries,
large well-designed studies are needed to clarify
whether there is an association between fitness, as
determined by CPEX testing, and outcome.
DISCUSSION
Overall, the evidence for associations between
preoperative CPEX values and postoperative
outcome after cancer resection surgery is mostly
derived from small observational studies. Many
were underpowered to report on mortality risk.
However, in the largest study of its kind, a low
VO2peak was associated with mortality after lung
cancer resection, but only in thoracotomy sur-
gery (not in VATS) (12). For morbidity, preoper-
ative CPEX testing has poor (19, 24, 25) to aver-
age (20) discriminatory accuracy to predict post-
operative outcomes after cancer resection sur-
gery, so has limited utility as an isolated preoper-
ative screening tool. Furthermore, investigations
often used composite outcomes and included
low Clavien-Dindo graded complications (19,
20, 23), which reduces the clinical meaningful-
ness of associations found (40). Much research
in CPEX testing has been a continuation of the
seminal work of Older et al, in a paper pub-
lished in 1993; reporting that AT may predict
postoperative cardiac-related death after major
surgery (7). However, there seems to have been
incorrect interpretations of this original plausi-
ble hypothesis. Cardiac-related death has a rela-
tionship with aerobic fitness; mortality events
are a reflection of how patients respond once
complications have occurred (41). Patients that
die as a result of such complications are likely to
lack the necessary cardiopulmonary and muscu-
loskeletal reserves, which are required when
there are ongoing physiological stresses and pro-
longed ITU bed-rest (41). These outcomes are
very different to those measured in some of the
CPEX studies in this review, which include surgi-
cal wound infection on postoperative day 3 (23)
or increased analgesia need due to postoperative
pain (as measured by POMS) (20, 33). Ideally,
observational studies investigating cardiac death
are required, but pragmatically may be difficult
due to the small number of such events. Howev-
er, to justify the pre-operative use of CPEX in
cancer surgery, it should be shown that CPEX
can accurately identify patients at risk of signifi-
cant postoperative complications.
This is the first review to assess the utility of
preoperative CPEX to predict postoperative
complications after major cancer resection sur-
gery. And, whilst it is plausible that greater car-
diopulmonary and skeletal muscle reserves (as
measured by CPEX) could reduce postoperative
complications following major cancer resection
surgery, evidence from the reviewed observation-
al studies suggests that the effect size, if present
at all, is likely to be small. This unintuitive find-
ing may be explained by the size of the physio-
logical insult associated with major cancer resec-
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tion surgery. Taking oesophagectomy as an ex-
ample; resection and reconstruction of the up-
per gastrointestinal tract results in a complica-
tion profile reflective of the operative field rath-
er than fitness, where the cardiopulmonary sys-
tem is directly affected. However, cardiorespira-
tory and musculoskeletal reserves may be critical
to the ability of a patient to respond once a com-
plication has occurred (41). This review high-
lights the need for large multi-center studies to
assess the association between CPEX variables
and mortality in cancer resection surgery. Until
this evidence is available, CPEX testing in isola-
tion is unlikely to meaningfully inform cancer
surgery practice.
The authors declare no other conflicts of competing interest for this work.
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Search terms
Search terms for cardiopulmonary exercise testing:
“cardiopulmonary exercise”, “CPEX”, “CPET”, “exercise testing”, “anaerobic threshold”,
“VCO2”, “ventilatory inefficiency”, “oxygen consumption”, “VO2”, “preoperative exercise”, “aero-
bic exercise”.
Search terms for outcomes: “morbidity”, “mortality”, “outcome”, “complication”.
Additional search terms for lung cancer: “lung cancer surgery”, “lung resection”, “lobectomy”, “pneu-
monectomy”.
Additional search terms for colorectal cancer: “colorectal”, “colon”, “colectomy”, “rectal”, “rectum”,
“surgery”, “resection”.
Additional search terms for colorectal cancer: “hepatic”, “hepatectomy”, “liver surgery”.
Additional search terms for oesophageal cancer: “oesophagectomy”, “oesophagogastrectomy”.
Additional search terms for bladder cancer: “bladder cancer”, “cystectomy”.
Additional search terms for pancreatic cancer: “pancreatic surgery”, “pancreatic resection”, “pancreat-
icoduodenectomy”.
An example for the whole search string for colorectal cancer: “(((cardiopulmonary exercise).ti,ab OR
(cpex).ti,ab OR (cpet).ti,ab OR (exercise testing).ti,ab OR (anerobic threshold).ti,ab OR (VCO2).ti,ab
OR (ventilatory inefficiency).ti,ab OR (oxygen consumption).ti,ab OR (VO2).ti,ab OR (preoperative
exercise).ti,ab OR (aerobic exercise).ti,ab) AND (((colorectal).ti,ab OR (colon).ti,ab OR (colectomy).
ti,ab OR (rectal).ti,ab OR (rectum).ti,ab) AND ((surgery).ti,ab OR (resection).ti,ab))) AND ((complica-
tions).ti,ab OR (outcome).ti,ab OR (morbidity).ti,ab OR (mortality).ti,ab)”
ti=title, ab=abstract
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